findmyKOL

Shari Lipner

Basic profile

Cornell University

ORCID↗NPI↗
✓ Full record
RegionNew York, NY · NortheastSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL type: NationalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Shari Lipner is a Dermatology physician affiliated with Cornell University. OpenAlex indexes 884 publications with 5,953 citations (h-index 36); ClinicalTrials.gov lists 11 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
884publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,953citations

Total citations across indexed works.

36h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11clinical trials

Investigator role on registered studies.

View trials ↓
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1305 York Ave
New York, NY 100215663

Telephone

646-962-3376

Registry record last updated 9 Dec 2011.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    43.9%
    Corticosteroid20.8%
    Triamcinolone Acetonide54%Triamcinolone acetonide30%Fluocinolone Acetonide17%
    Part D + Part B<11 patients
    alpha-Hydroxy Acid11.3%
    Ammonium Lactate100%
    Part D≥62 patients

    + 4 more classes in this area

  • Sensory organs

    17.2%
    Corticosteroid14%
    Clobetasol Propionate55%Hydrocortisone45%
    Part D≥31 patients
    Aminoglycoside Antibacterial3.2%
    Gentamicin Sulfate100%
    Part D≥14 patients
  • Anti-infectives

    12.8%
    Azole Antifungal5.9%
    Ketoconazole100%
    Part D≥23 patients
    Nitroimidazole Antimicrobial2.5%
    Metronidazole100%
    Part D≥12 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”